Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CETP | P11597 | 10/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.42 |
| ▸ | DRD2 | P14416 | 1/20 | 0.39 |
| ▸ | DRD4 | P21917 | 1/20 | 0.39 |
| ▸ | DRD3 | P35462 | 1/20 | 0.39 |
| ▸ | GPR119 | Q8TDV5 | 3/20 | 0.37 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.36 |
| ▸ | F2 | P00734 | 1/20 | 0.35 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.35 |
| ▸ | TPSD1 | Q9BZJ3 | 1/20 | 0.35 |
| ▸ | TPSG1 | Q9NRR2 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8904008 | 0.86 | CETP (0.43) | CETPHRH3DRD2DRD4DRD3 | |
| SCHEMBL8715642 | 0.86 | CETP (0.43) | CETPHRH3DRD2DRD4DRD3 | |
| SCHEMBL8903224 | 0.86 | HRH3 (0.46) | CETPHRH3DRD2DRD4DRD3 | |
| SCHEMBL8715740 | 0.83 | F2 (0.53) | F2TPSAB1TPSD1TPSG1 | |
| SCHEMBL8717784 | 0.75 | HRH3 (0.46) | HRH3DRD2DRD4DRD3TPSAB1 | |
| SCHEMBL8715681 | 0.72 | MAPT (0.46) | CETPDRD2DRD4DRD3L3MBTL1 | |
| SCHEMBL7449870 | 0.72 | CA12 (0.50) | HRH3 | |
| SCHEMBL8712830 | 0.72 | DRD2 (0.45) | HRH3DRD2DRD4DRD3 | |
| SCHEMBL8716441 | 0.72 | NPC1 (0.46) | CETP | |
| SCHEMBL8905478 | 0.72 | NPC1 (0.46) | CETP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5753670-A | ANTICOAGULANTS | THE GREEN CROSS CORPORATION (JP) | 1998-05-19 | — | — | US | disclosed |